Cargando…
Characterization of a Tumor-Associated Activating Mutation of the p110β PI 3-Kinase
The PI3-kinase pathway is commonly activated in tumors, most often by loss of PTEN lipid phosphatase activity or the amplification or mutation of p110α. Oncogenic mutants have commonly been found in p110α, but rarely in any of the other catalytic subunits of class I PI3-kinases. We here characterize...
Autores principales: | Dbouk, Hashem A., Khalil, Bassem D., Wu, Haiyan, Shymanets, Aliaksei, Nürnberg, Bernd, Backer, Jonathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667187/ https://www.ncbi.nlm.nih.gov/pubmed/23734178 http://dx.doi.org/10.1371/journal.pone.0063833 |
Ejemplares similares
-
A beta version of life: p110β takes center stage
por: Dbouk, Hashem A., et al.
Publicado: (2010) -
PI3Kβ downstream of GPCRs – crucial partners in oncogenesis
por: Dbouk, Hashem A., et al.
Publicado: (2012) -
Deficiency of PI3-Kinase catalytic isoforms p110γ and p110δ in mice enhances the IL-17/G-CSF axis and induces neutrophilia
por: Bucher, Kirsten, et al.
Publicado: (2017) -
Oncogenic Mutations of p110α Isoform of PI 3-Kinase Upregulate Its Protein Kinase Activity
por: Buchanan, Christina M., et al.
Publicado: (2013) -
Regulation of p110δ PI 3-Kinase Gene Expression
por: Kok, Klaartje, et al.
Publicado: (2009)